Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

US-based Filipino chemist Dr. Webster L. Santos has discovered and patented a groundbreaking new class of small-molecule drugs for treating acute kidney injury (AKI) and autoimmune diseases. In an ...

Acute Kidney Injury Treatment MarketThe global Acute Kidney Injury (AKI) Treatment Market is poised for significant growth, ...

had onset of AKI during anti-TB treatment. Acute kidney injury (AKI) was defined according to the criteria established by the Acute Kidney Injury Network (AKIN) and was classified into three ...

AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...

• Fenoldopam (a medicine that rapidly widens and relaxes blood vessels) probably reduces the risk of developing acute kidney injury (AKI) (a condition where the kidneys suddenly lose their ability to ...

Acute kidney injury (AKI) often occurs as a result of ischemia, which is a condition in which blood flow to part of the body ...

Acute kidney injury (AKI) often occurs as a result of ischemia, which is a condition in which blood flow to part of the body ...

Discover how machine learning predicts successful discontinuation of renal replacement therapy in critically ill patients ...

A medication side effect or a blockage may occasionally cause acute kidney injury. Once your doctor identifies the cause, kidney function may improve with treatment. No cure is available for CKD ...